This study compares the readability and accuracy of patient-oriented online resources for pancreatic cancer by treatment modality and website affiliation.
This cell biology study compares cytotoxic T cell lysis of in vitro pancreatic cancer cells with vs without tumor antigen expression induced by cell-penetrating peptide.
This cohort study investigates the associations between socioeconomic variables and surgical resection in patients with early-stage pancreatic cancer.
This Surgical Innovation discusses the applications arising from nanotechnology for therapeutic and diagnostic use in cancer.
This prospective observational study demonstrates that a noninvasive magnetic resonance imaging–based screening protocol in individuals at risk for pancreatic cancer is effective at determining cancer risk. Talamonti provides a related invited commentary.
This retrospective cohort study reports that implementation of a multidisciplinary hepatopancreaticobiliary surgical program leads to regionalization of care and improved quality of cancer care and surgical outcomes.
Gall et al examine the impact of 2 different surgical techniques, standard pancreaticoduodenectomy and no-touch isolation pancreaticoduodenectomy, on tumor behavior and outcome in patients with pancreatic cancer by using circulating tumor cells as biomarkers.
Kadera and colleagues aimed to perform a detailed survival analysis of their institution’s experience with patients with locally advanced/borderline resectable pancreatic ductal adenocarcinoma who were downstaged and underwent surgical resection and (2) identify prognostic biomarkers that may help guide a decision for the use of adjuvant therapy in this patient subgroup. L. Andrew DiFronzo, MD, provided an invited commentary.